[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 437,787
  • Shares Outstanding, K 310,487
  • Annual Sales, $ 160,010 K
  • Annual Income, $ -546,380 K
  • EBIT $ -174 M
  • EBITDA $ 223 M
  • 60-Month Beta 2.40
  • Price/Sales 3.20
  • Price/Cash Flow 2.09
  • Price/Book 93.13

Options Overview Details

View History
  • Implied Volatility 93.58% (+6.81%)
  • Historical Volatility 85.51%
  • IV Percentile 7%
  • IV Rank 5.27%
  • IV High 302.81% on 06/09/25
  • IV Low 81.94% on 04/14/26
  • Expected Move (DTE 5) 0.1275 (9.04%)
  • Put/Call Vol Ratio 0.09
  • Today's Volume 2,447
  • Volume Avg (30-Day) 1,812
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 70,648
  • Open Int (30-Day) 63,559
  • Expected Range 1.2825 to 1.5375

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.13
  • Number of Estimates 1
  • High Estimate $-0.13
  • Low Estimate $-0.13
  • Prior Year $-0.13
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3100 +7.63%
on 04/10/26
1.8000 -21.67%
on 04/21/26
-0.0600 (-4.08%)
since 04/08/26
3-Month
1.2300 +14.63%
on 03/27/26
2.0000 -29.50%
on 02/13/26
-0.4100 (-22.53%)
since 02/06/26
52-Week
0.8500 +65.88%
on 05/28/25
2.7300 -48.35%
on 01/23/26
+0.2100 (+17.50%)
since 05/08/25

Most Recent Stories

More News
Why PacBio (PACB) Shares Are Getting Obliterated Today

Why PacBio (PACB) Shares Are Getting Obliterated Today

PACB : 1.4100 (-14.55%)
PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness

PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness

PACB : 1.4100 (-14.55%)
Pacific Biosciences of California Q1 Earnings Call Highlights

Pacific Biosciences of California (NASDAQ:PACB) reported first-quarter 2026 revenue of $37.2 million, roughly flat year over year, as record consumables revenue offset weaker-than-expected instrument performance...

PACB : 1.4100 (-14.55%)
3 Small-Cap Stocks We Find Risky

3 Small-Cap Stocks We Find Risky

APPN : 21.92 (-7.74%)
PACB : 1.4100 (-14.55%)
TEN : 43.80 (-0.45%)
Pacific Biosciences: Q1 Earnings Snapshot

Pacific Biosciences: Q1 Earnings Snapshot

PACB : 1.4100 (-14.55%)
PacBio (NASDAQ:PACB) Misses Q1 CY2026 Sales Expectations

PacBio (NASDAQ:PACB) Misses Q1 CY2026 Sales Expectations

PACB : 1.4100 (-14.55%)
PacBio Announces First Quarter 2026 Financial Results

MENLO PARK, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2026. Recent Business Highlights Selected by Basecamp...

PACB : 1.4100 (-14.55%)
Pacific Biosciences: Can Clinical Momentum Offset What Looks Like an Academic Funding Freeze?

Barchart Research What to Expect from PACB Earnings PACB Generated May 6, 2026 Current Price $1.7100 EPS Estimate $$-0.17 Consensus Rating Moderate Buy Average Move 8.89% Pacific Biosciences: Can Clinical...

PACB : 1.4100 (-14.55%)
PacBio (PACB) Q1 Earnings Report Preview: What To Look For

PacBio (PACB) Q1 Earnings Report Preview: What To Look For

PACB : 1.4100 (-14.55%)
1 Cash-Burning Stock with Solid Fundamentals and 2 We Turn Down

1 Cash-Burning Stock with Solid Fundamentals and 2 We Turn Down

PACB : 1.4100 (-14.55%)
DNUT : 3.60 (-1.10%)
RKLB : 105.47 (+34.22%)

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 1.6733
2nd Resistance Point 1.5967
1st Resistance Point 1.5033
Last Price 1.4100
1st Support Level 1.3333
2nd Support Level 1.2567
3rd Support Level 1.1633

See More

52-Week High 2.7300
Fibonacci 61.8% 2.0118
Fibonacci 50% 1.7900
Fibonacci 38.2% 1.5682
Last Price 1.4100
52-Week Low 0.8500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.